slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 213,571-213,600
Pages 10,126
Rows per page 30
Component
213,571-213,600 of 303,780
17
The slide includes a detailed reconciliation table and a legend for specific adjustments (A-F).Cano Health | Results Presentation Deck | 19 slides · Cano Health
Conference presentation Investor relations Beat · Financials1 hit
01
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
02
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
03
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
04
The slide uses a Gantt-style chart to map drug candidates against development phases.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
05
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
06
Includes Kaplan-Meier survival curves and a comparative table of clinical outcomes.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · Problem StatementLoop · Cost Of Inaction1 hit
07
Data presented includes ORR, DOR, time to response, disease control rate, PFS, and overall survival metrics.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
08
The slide details specific inclusion/exclusion criteria including age, mutation status, disease progression, prior therapy, and washout periods.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
09
The slide highlights clinical response rates (20-26%) and disease control rates (40-42%) using rigorous BICR methodology.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
10
The chart is a waterfall plot (often called a swimmer plot or spider plot in oncology, but specifically a waterfall plot here).Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
11
The slide uses a waterfall plot to visualize tumor shrinkage (Best % Change in SPD) across different patient performance status cohorts.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
12
The chart is a 'spider plot' or 'swimmer plot' variant showing % change in tumor size over time.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
13
Presents safety data tables for two distinct patient populations.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
14
Data table comparing All patients vs RANO HGG Responders vs RANO HGG and/or LGG Responders across survival and clinical metrics.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
15
The table uses a color-coded heatmap (green/pink) to indicate positive vs negative characteristics of trial design and outcomes.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
16
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
17
The slide uses a process flow diagram to illustrate the clinical trial structure.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
18
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
19
The slide details specific statistical success thresholds for different trial endpoints.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
20
The chart shows a dose-response curve where longer incubation times (48+ hours) shift the curve to the left compared to 24 hours, indicating higher potency/efficacy with sustained exposure.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · Solution1 hit
21
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
22
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · Market Sizing1 hit
23
The slide lists specific regulatory milestones achieved for glioma treatments.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
24
Clinical trial data (NCT03034200) presented at ASCO 2021.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
25
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
27
Includes PET scan imagery and comparative bar/dot plots.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
28
Includes a schematic of the mutation, a bar chart of H3K27me3 levels, a Kaplan-Meier survival curve, and a dot plot showing treatment effect.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
29
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
30
Includes molecular structure of ONC206 and protein structures for DRD2 and ClpP.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit